Innovasis, Inc. is recalling 568 units of its TxHA PEEK IBF and TxTiHA IBF System Implant Trials due to mechanical interfacing issues between the trial device and the inserter tool used during spinal surgery. These devices are intended to help surgeons stabilize spinal segments and promote fusion to reduce pain. Because the trial may not connect correctly to the insertion tool, surgeons should contact the manufacturer immediately for guidance. This recall affects various sizes and angles of the lumbar intervertebral fusion device trials distributed across nine U.S. states.
A failure in the interface between the implant trial and the inserter can cause the device to function improperly during spinal surgery, potentially leading to surgical delays or complications during the placement of the fusion device. While no specific injuries are mentioned, the mechanical issue poses a risk to patients undergoing orthopedic spinal procedures.
Manufacturer correction/instruction following identified interfacing issues.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.